← Back to Search

Brain Stimulation for Cognitive Functioning

N/A
Recruiting
Research Sponsored by Colorado State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up single study appointment. 1 hour. there will be no follow up.
Awards & highlights

Study Summary

This trial is testing how different parameters of transcranial magnetic stimulation affects cognition, in order to optimize TMS as a cognitive measurement tool.

Who is the study for?
This trial is for right-handed, English-speaking individuals without significant medical or neurological issues. It excludes those with a history of severe headaches, syncope, head injuries, psychiatric disorders, substance abuse, hearing/visual impairments affecting cognition, metal implants in the head/neck (except dental), and certain medical devices.Check my eligibility
What is being tested?
The study is testing how Transcranial Magnetic Stimulation (TMS) affects cognitive task performance. Researchers are looking to find the best parameters for using TMS to measure its impact on cognitive functions.See study design
What are the potential side effects?
Potential side effects from TMS may include discomfort at the stimulation site, headache, lightheadedness or fainting. Rarely it could cause seizures but this is uncommon and precautions are taken to minimize risks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~single study appointment. 1 hour. there will be no follow up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and single study appointment. 1 hour. there will be no follow up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sternberg Memory Task (Accuracy)
Sternberg Memory Task (Reaction Time)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active TMSExperimental Treatment1 Intervention
Repetitive TMS for the brain
Group II: Sham TMSPlacebo Group1 Intervention
Scalp stimulation that does not affect the brain.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation
2017
Completed Phase 4
~730

Find a Location

Who is running the clinical trial?

Colorado State UniversityLead Sponsor
125 Previous Clinical Trials
38,259 Total Patients Enrolled

Media Library

Active TMS Clinical Trial Eligibility Overview. Trial Name: NCT05556655 — N/A
Cognitive Functioning Research Study Groups: Active TMS, Sham TMS
Cognitive Functioning Clinical Trial 2023: Active TMS Highlights & Side Effects. Trial Name: NCT05556655 — N/A
Active TMS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05556655 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical study permit participants over the age of 35?

"Based on the trial's criteria, only those aged 18 to 65 can be considered eligible. For minors and seniors respectively, there are 1 study and 11 studies that may qualify them for participation."

Answered by AI

Who has the eligibility to join this research project?

"Eligible participants must be of sound mental capacity and fall between 18 to 65 years old. This medical trial has the goal of recruiting a total of 100 patients."

Answered by AI

Is this medical experiment recruiting participants at present?

"Clinicaltrials.gov informations states that this trial is not currently recruiting participants, even though it was initially posted on January 1st 2023 and last modified September 22nd 2022. However, there are still a total of twenty other clinical trials actively seeking patients at this moment in time."

Answered by AI
~40 spots leftby Jan 2025